📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Targeting AXL Using the AVB-500 Soluble Receptor and through Genetic Knockdown Inhibits Bile Duct Cancer Growth and Metastasis. (2023)

First Author: Kim J

Attributed to: Transcriptional regulation of redox pathways funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3390/cancers15061882

PubMed Identifier: 36980768

Publication URI: http://europepmc.org/abstract/MED/36980768

Type: Journal Article/Review

Volume: 15

Parent Publication: Cancers

Issue: 6

ISSN: 2072-6694